Convexity Labs

CB

Convexity Analyst · CB
Holdmedium confidenceTactical · no named thesis
Generated Jun 21, 2026

Analyst Note: Chubb Limited (CB)

Date: 2026-06-13 Current Price: $323.40

1. Structural Readiness

  • Conservative Entry: — (Awaiting confirmed breakout above the coil resistance)
  • Aggressive/Pre-Breakout Entry: — (Not actionable on setup alone; requires confirmation)
  • Breakout Level: — (Defined by the upper resistance of the forming coil structure)
  • Current Price: $323.40
  • Extension: — (No extension data provided; price is within the consolidation range)
  • ATR Context: Current ATR is 2.0% (sub-threshold). This indicates lower volatility than the historical "sweet spot" (4–6%), suggesting the market is currently in a low-volatility consolidation phase rather than an active trend expansion.

2. Thesis Layer

As of 2026-06-13, there is no named secular thesis attached to this setup. This is a TACTICAL, setup-led name. The conviction must be derived strictly from the quality of the technical structure (the forming coil) and the underlying business fundamentals reported in the most recent filings. No macro or thematic thesis should be invented to support the trade; the setup itself is the primary driver.

3. Business Overview

Chubb Limited is a global insurance and reinsurance organization headquartered in Zurich, Switzerland, operating in 54 countries and territories. The company serves a diverse group of clients through commercial and consumer P&C insurance, accident and health (A&H), reinsurance, and life insurance.

Key Business Segments & Performance (as of Q1 2026 and FY 2025):

  • P&C Underwriting: The company demonstrated strong underwriting discipline. In Q1 2026, P&C underwriting income was $1.8 billion with a combined ratio of 84% (E2). Consolidated net premiums written for the quarter were $14.01 billion, up 10.7% year-over-year (E11).
  • *North America Commercial:* Up 4.1% (or 7.8% excluding large account property) (E5).
  • *North America Personal:* Consumer insurance up 14.2% (E12).
  • *International:* Overseas retail business premiums up more than 15% (E6).
  • Life Insurance: A significant growth driver, with net premiums written increasing 33.1% (or 30.8% in constant dollars) in Q1 2026, driven by international life growth of 34.1% (E13).
  • Reinsurance: Operates under the Chubb Tempest Re brand, offering traditional and specialty reinsurance globally (E30).
  • Investment Income: Adjusted net investment income for Q1 2026 was $1.84 billion, landing at the top end of the previously guided range (E3). Management expects Q2 2026 adjusted net investment income to be between $1.825 billion and $1.85 billion (E4).
  • Catastrophe Losses: Total pre-tax catastrophe losses were $500 million in Q1 2026, a significant improvement compared to $1.64 billion in the prior year period, which included $1.47 billion from California wildfires (E16).
  • Strategic Holdings: At December 31, 2025, Chubb held an 87.2% ownership interest in Huatai Group, an asset management firm with over $155 billion in AUM in China (E23, E24).

4. Archetype and Conviction

  • Archetype: Growth Leader (with defensive characteristics).
  • *Fit:* The company exhibits double-digit premium growth across multiple segments (Life +33%, Consumer P&C +14%, International +15%) while maintaining underwriting discipline (84% combined ratio). The reduction in catastrophe losses and strong investment income supports a "quality compounder" narrative within a defensive sector.
  • Valuation Context: The financial spine indicates a forward consensus EPS of $27.10 for FY1 and $29.28 for FY2 (E33).
  • Conviction Stack:
  • *Thesis Strength:* Low (Tactical only; no macro thesis).
  • *Evidence Quality:* High. Recent earnings (April 2026) and filings (April 2026) provide robust, quantitative data on growth, margins, and loss ratios.
  • *Rerating Potential:* Moderate. The combination of strong growth (Life/International) and improved loss ratios (catastrophes) provides a fundamental basis for a multiple expansion if the technical breakout occurs.

5. Invalidations, Strengtheners, and Gaps

  • Strengtheners: A confirmed breakout above the coil resistance with volume expansion. Continued adherence to the Q2 investment income guidance ($1.825B–$1.85B) and sustained premium growth in the Life and International segments.
  • Gaps in Evidence:
  • Breakout Level: The specific resistance level defining the breakout is not quantified.
  • Management Guidance for Full Year 2026: While Q2 investment income is guided, full-year 2026 EPS guidance or full-year premium growth targets are not explicitly detailed in the provided evidence block beyond the FY1/FY2 consensus estimates.

PRIVATE ANALYST CALL

Judgment: Hold Confidence: medium Key evidence: Q1 2026 P&C combined ratio of 84% and $1.8B underwriting income; Life premiums up 33.1% YoY; Catastrophe losses reduced to $500M from $1.64B YoY. Key risks: Technical setup is forming but not confirmed (no breakout); ATR is sub-threshold (2.0%) indicating low volatility and potential for stagnation; No named secular thesis to support a tactical entry. Sizing hint: Position size should be minimal or zero until a confirmed breakout occurs; do not size based on the forming coil alone. Expected path: Management expects investment income to remain stable in Q2 ($1.825B–$1.85B); structural implication is that the stock is consolidating gains from the strong Q1 print before a potential expansion. Expected horizon: 3 to 6 months for the coil structure to resolve into a breakout or breakdown.

Loading chart...
Exhibit 1: CB daily candlestick — no active setup overlay.

Source-backed evidence anchors and catalysts land once Convexity finishes coverage for CB.

Core assumptions for this name haven't been articulated yet — they land alongside the rerating thesis.

Value picture unavailable — no financial spine on file for CB.

Layer B fundamentals snapshot not yet available. Highlights land once Convexity finishes the classification.

Coverage: